MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Parotid Tumor Clinical Trial

— Parotid  

Official title:

Role of MRI and Fine Needle Aspiration in the Diagnosis of Parotid Tumors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05152056
• Other study ID #: 8454
• Status: Completed
• Start date: November 15, 2021
• Est. completion date: December 9, 2021

Study information

• Verified date: November 2021
• Source: University Hospital, Strasbourg, France
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

What value is given to MRI diffusion and perfusion sequences in the diagnosis of parotid tumors? Is a fine needle aspiration associated with MRI systematically necessary? The aim of the research is to study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 133
• Est. completion date: December 9, 2021
• Est. primary completion date: December 9, 2021
• Gender: All
• Age group: 6 Years and older

Eligibility

Inclusion criteria:

• Major subject (=18 years old)

• Minor subject (<18 years old)

• Operated for a parotid tumor at Strasbourg University Hospital between January 2009 and June 2020

• Having had in the preoperative assessment an MRI of the parotid, also carried out at the Strasbourg University Hospital.

• Subject (and / or his parental authority) not having expressed, after being informed, his opposition to the reuse of his data for the purposes of this research.

Exclusion criteria:

• Subject (or his parents) who expressed his (their) opposition to participating in the study

• Lack of pathological or MRi results

• Subject under guardianship, curatorship or safeguard of justice

Related Conditions & MeSH terms

• Parotid Neoplasms
• Parotid Tumor

Locations

Country	Name	City	State
France	Service d'ORL et de Chirurgie Cervico-Faciale - Hôpitaux Universitaires de Strasbourg	Strasbourg

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Study the performance of diffusion and perfusion MRI sequences in the diagnosis of parotid tumors on a large series of cases		Files analysed retrospectively from January 1, 2009 to June 30, 2020 will be examined]